Identifying domains for CNO and SAPHO: A scoping review to create domains from existing outcomes by the OMERACT CNO and SAPHO working group.
Document Type
Article
Publication Date
12-2025
Identifier
DOI: 10.1016/j.semarthrit.2025.152862
Abstract
INTRODUCTION: Chronic nonbacterial osteomyelitis (CNO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome are autoinflammatory bone diseases of unknown etiology that present with bone pain and varying degrees of extraosseous manifestations such as skin, intestinal and joint involvement. Currently, there are no validated outcome measurement sets that represent the input from all collaborating groups.
METHODS: The OMERACT CNO & SAPHO working group performed a scoping review to identify domains previously used in CNO and SAPHO clinical studies. The list of potential domains was narrowed through a process of binning and winnowing.
RESULTS: A scoping review included 260 observational studies published from 1978 -2020 and 220 domains were initially identified. Domains were reduced to 25 through a binning and winnowing process. Domains cover each of the OMERACT core with most domains mapped to life impact and pathophysiological manifestations.
CONCLUSION: We identified 25 potential domains covering health concepts of function, disease manifestations, pain, and impact on mental health and societal participation to be included in the final core domain set. The next step will be to reach a consensus on the final CNO & SAPHO core domain set and begin instrument selection.
Journal Title
Seminars in arthritis and rheumatism
Volume
75
First Page
152862
Last Page
152862
MeSH Keywords
Humans; Acquired Hyperostosis Syndrome; Osteomyelitis; Outcome Assessment, Health Care
PubMed ID
41270570
Keywords
Autoinflammatory disease; Chronic nonbacterial osteomyelitis; Core domain set; OMERACT; Scoping review
Recommended Citation
Oliver M, Nuruzzaman F, Lenert A, et al. Identifying domains for CNO and SAPHO: A scoping review to create domains from existing outcomes by the OMERACT CNO and SAPHO working group. Semin Arthritis Rheum. 2025;75:152862. doi:10.1016/j.semarthrit.2025.152862

